X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (61) 61
psychiatry (58) 58
neurosciences (48) 48
schizophrenia (47) 47
humans (46) 46
male (36) 36
animals (35) 35
pharmacology & pharmacy (33) 33
clinical neurology (27) 27
dopamine (25) 25
adult (20) 20
female (20) 20
bipolar disorder (18) 18
gene expression (17) 17
glutamate (17) 17
rats (17) 17
antipsychotic agents - therapeutic use (16) 16
psychosis (16) 16
rats, sprague-dawley (16) 16
schizophrenia - drug therapy (16) 16
antipsychotics (15) 15
homer (15) 15
homer scaffolding proteins (14) 14
prefrontal cortex (14) 14
antipsychotic drugs (13) 13
drug therapy (13) 13
haloperidol (13) 13
proteins (13) 13
antipsychotic agents - pharmacology (12) 12
analysis (11) 11
depression (11) 11
middle aged (11) 11
psd-95 (11) 11
young adult (11) 11
cerebral cortex - drug effects (10) 10
major depressive disorder (10) 10
mental disorders (10) 10
psychotropic drugs (10) 10
review (10) 10
rna, messenger - metabolism (10) 10
antipsychotic agents - administration & dosage (9) 9
clozapine (9) 9
disks large homolog 4 protein (9) 9
double-blind (9) 9
gene-expression (9) 9
negative symptoms (9) 9
anxiety (8) 8
brain - drug effects (8) 8
carrier proteins - genetics (8) 8
cognition (8) 8
efficacy (8) 8
gene expression - drug effects (8) 8
haloperidol - pharmacology (8) 8
obsessive-compulsive disorder (8) 8
post-synaptic density - metabolism (8) 8
research (8) 8
treatment outcome (8) 8
adolescent (7) 7
antidepressants (7) 7
antidepressive agents - therapeutic use (7) 7
atypical antipsychotics (7) 7
brain - metabolism (7) 7
carrier proteins - metabolism (7) 7
cerebral cortex - metabolism (7) 7
corpus striatum - drug effects (7) 7
depression, mental (7) 7
genes (7) 7
intracellular signaling peptides and proteins - metabolism (7) 7
membrane proteins - metabolism (7) 7
methyl aspartate (7) 7
nerve tissue proteins - metabolism (7) 7
post-synaptic density - drug effects (7) 7
scaffolding proteins (7) 7
scale (7) 7
synaptic plasticity (7) 7
aged (6) 6
bipolar disorder - drug therapy (6) 6
corpus striatum - metabolism (6) 6
cortex (6) 6
cross-sectional studies (6) 6
depressive disorder, major - drug therapy (6) 6
drug therapy, combination (6) 6
gene expression regulation - drug effects (6) 6
health aspects (6) 6
homer1 (6) 6
medical research (6) 6
medicine, experimental (6) 6
nmda receptor (6) 6
psychiatric-disorders (6) 6
psychotic disorders - metabolism (6) 6
schizophrenic psychology (6) 6
serotonin (6) 6
abstracts (5) 5
antipsychotic (5) 5
antipsychotic agents - adverse effects (5) 5
article subject (5) 5
biochemistry & molecular biology (5) 5
bipolar disorder - psychology (5) 5
care and treatment (5) 5
glutamic acid - metabolism (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuron, ISSN 0896-6273, 08/2015, Volume 87, Issue 3, pp. 549 - 562
Major depressive disorder is among the most commonly diagnosed disabling mental diseases. Several non-pharmacological treatments of depression upregulate... 
Proteins | Neurosciences | Brain research | Sleep | Neurons | Rodents | Protein expression | Behavior | Gene expression | Investigations
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 2/2014, Volume 49, Issue 1, pp. 484 - 511
Emerging researches point to a relevant role of postsynaptic density (PSD) proteins, such as PSD-95, Homer, Shank, and DISC-1, in the pathophysiology of... 
Psychosis | Neurology | Antipsychotics | Neurosciences | Synapse | Biomedicine | Neurobiology | Homer | Shank | PSD-95 | Cell Biology | DIFFERENTIAL EXPRESSION | INTERACTING PSD PROTEINS | NMDA RECEPTOR SUBUNIT | DISC1 TRANSGENIC MICE | NEUROSCIENCES | PREFRONTAL CORTEX | EXCITATORY SYNAPSE | MESSENGER-RNA | LONG-TERM DEPRESSION | ANTIPSYCHOTIC-DRUGS | GENETIC MOUSE MODELS | Disks Large Homolog 4 Protein | Child Development Disorders, Pervasive - metabolism | Schizophrenia - metabolism | Humans | Mental Disorders - metabolism | Child Development Disorders, Pervasive - physiopathology | Dendritic Spines - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Synapses - pathology | Child Development Disorders, Pervasive - drug therapy | Mental Disorders - physiopathology | Antipsychotic Agents - administration & dosage | Nerve Tissue Proteins - metabolism | Animals | Neuronal Plasticity - physiology | Synapses - metabolism | Mental Disorders - drug therapy | Schizophrenia - physiopathology | Dendritic Spines - pathology | Glutamic Acid - metabolism | Membrane Proteins - metabolism | Drug Delivery Systems - trends | Schizophrenia - drug therapy | Proteins | Brain | Antipsychotic drugs | Genetically modified organisms | Schizophrenia | Genetic engineering | Glutamate | Health aspects | Psychotropic drugs | Autism | Neuroses
Journal Article
Journal Article
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 01/2015, Volume 16, Issue 1, pp. 1111 - 1130
Agomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine's... 
schizophrenia | melatonergic receptors | agomelatine | bipolar depression | anxiety | serotonin | alcohol dependence | fibromyalgia | noradrenaline | melatonin | migraines | dopamine | seasonal affective disorder | psychiatric disorders | Seasonal affective disorder | Melatonin | Dopamine | Serotonin | Fibromyalgia | Schizophrenia | Alcohol dependence | Bipolar depression | Migraines | Melatonergic receptors | Agomelatine | Anxiety | Noradrenaline | Psychiatric disorders | ANTIDEPRESSANT AGOMELATINE | REUPTAKE INHIBITORS | MELATONIN AGONIST AGOMELATINE | ADJUNCTIVE THERAPY | GENERALIZED ANXIETY DISORDER | CIRCADIAN-RHYTHM | BIOCHEMISTRY & MOLECULAR BIOLOGY | OPEN-LABEL | CHEMISTRY, MULTIDISCIPLINARY | OBSESSIVE-COMPULSIVE DISORDER | DOUBLE-BLIND | Acetamides - pharmacokinetics | Sleep Wake Disorders - drug therapy | Humans | Receptor, Serotonin, 5-HT2C - metabolism | Depressive Disorder - drug therapy | Bipolar Disorder - drug therapy | Migraine Disorders - drug therapy | Antidepressive Agents - therapeutic use | Acetamides - therapeutic use | Fibromyalgia - drug therapy | Receptor, Serotonin, 5-HT2C - chemistry | Schizophrenia - drug therapy | Antidepressive Agents - pharmacokinetics | Receptor, Melatonin, MT2 - metabolism | Receptor, Melatonin, MT1 - metabolism | Psychological aspects | Antidepressants | Anxieties | Mental depression | Drug use
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 4/2017, Volume 31, Issue 4, pp. 406 - 417
In this study, we investigated whether minocycline, a second-generation tetracycline proposed as an add-on to antipsychotics in treatment-resistant... 
treatment resistant schizophrenia | MICROGLIAL ACTIVATION | NEGATIVE SYMPTOMS | PSYCHIATRY | EARLY-PHASE SCHIZOPHRENIA | DOPAMINERGIC-NEURONS | NEUROSCIENCES | CLINICAL NEUROLOGY | Antipsychotics | NMDA RECEPTOR ANTAGONISTS | Homer1 | Arc | TRAUMATIC BRAIN-INJURY | MOUSE MODEL | N-methyl-D-aspartate receptor | DOUBLE-BLIND | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | SCAFFOLDING PROTEINS | Homer Scaffolding Proteins - metabolism | Schizophrenia - metabolism | Gene Expression - drug effects | Minocycline - pharmacology | Receptors, N-Methyl-D-Aspartate - metabolism | Rats | Male | Drug Resistance - drug effects | Intracellular Signaling Peptides and Proteins - metabolism | Rats, Sprague-Dawley | Cerebral Cortex - metabolism | Nerve Tissue Proteins - metabolism | Psychotic Disorders - metabolism | Animals | Membrane Proteins - metabolism | Post-Synaptic Density - drug effects | Psychotic Disorders - drug therapy | Antipsychotic Agents - pharmacology | Cerebral Cortex - drug effects | Post-Synaptic Density - metabolism | Schizophrenia - drug therapy | Ketamine - pharmacology | Haloperidol - pharmacology | Schizophrenia | Methyl aspartate | Usage | Care and treatment | Antipsychotic drugs | Research | Neuroleptics | Mental disorders | Glutamic acid receptors (ionotropic) | Cortex | N-Methyl-D-aspartic acid receptors | Glutamic acid receptors | Exposure | Haloperidol | Gene expression | Mimicry | Psychosis | Psychotropic drugs | Ketamine | Pathways | Topography | Rodents | Minocycline | Pretreatment | Glutamatergic transmission | Postsynaptic density
Journal Article
Current Neuropharmacology, ISSN 1570-159X, 05/2014, Volume 12, Issue 3, pp. 219 - 238
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 05/2012, Volume 682, Issue 1-3, pp. 1 - 11
Journal Article